[ad_1] Covid-19 vaccine manufacturer Novavax said Tuesday that there is “substantial doubt” about its ability to continue operating through this…
Read More »pfizer
[ad_1] Pfizer’s (PFE) interest in Seagen (SGEN) marks the second time in a year the cancer-focused biotech has been an…
Read More »[ad_1] Pfizer (PFE) is in early talks to acquire cancer specialist Seagen (SGEN), according to a report that sent SGEN…
Read More »[ad_1] This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients…
Read More »[ad_1] Multinational pharmaceutical company Pfizer is in discussions to acquire biotech firm Seagen in a deal that could be worth…
Read More »[ad_1] Pfizer stock is under pressure as the company braces for double-digit declines in sales of Covid products, Comirnaty and…
Read More »[ad_1] To the Editor: Pfizer has a lot of good and bad points, as mentioned in your cover story “Pfizer…
Read More »[ad_1] Pfizer probably did more than any other company to help the world normalize from the pandemic, and it reaped…
Read More »[ad_1] As investors face another uncertain year for public equities, large-cap healthcare stocks remain an attractive defensive play. They offer…
Read More »[ad_1] Drug stocks have been on fire lately, and over the past few weeks, the two leading covid-19 vaccine makers, Pfizer (PFE)…
Read More »